Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma - Huang, D; Ding, Y; Li, Y; Luo, W M; Zhang, Z F; Snider, J; Vandenbeldt, K; Qian, C N; Teh, B T (Cancer research, 2010)